The Social Dilemma of Health (SDoH).
In March 2018, the world was shocked when it became public knowledge that Cambridge Analytica, a company based in the United Kingdom, had used data from Facebook to impact the presidential election in the United States. It turned out that they had also provided data to the groups supporting Brexit in the U.K.
It should not be a surprise that Facebook had shared data on its users for profit. Facebook said they allowed some access to Cambridge Analytica, but the company had used survey questions to hack into Facebook data, in a manner not intended by Facebook. I am dubious about this claim. The old saying in technology is that if the product is free, then the user is the product.
The business models of Facebook, Twitter, Instagram, and TikTok are similar in that the service to users is free. Companies that wish to advertise on these platforms get the benefit of placing the user’s eyeballs on screens where advertisements are seen.
First, advertisers get access to the age, race, sex, and lots of other demographic information on the people that click on the advertisers’ “landing pages” from the social media platform. This is the information companies get when you simply access their site.
Media companies like Facebook also know what social groups you joined and, critically, with whom you are connected. They create user “profiles” with various amounts of sensitive data.
In the case of Cambridge Analytica, they obtained 87 million Facebook user profiles. Included with these profiles were Facebook pages each user “liked.” Also included in the profiles were the user’s date of birth and location.
In the case of Google, in exchange for answering users’ Internet searches, the company has information not just on what was searched for, but in many cases, on every location users have been, sometime for years.
Let’s go back to our first observation about social media companies. Users are the product. While Facebook apologized for the Cambridge Analytica breach, what they didn’t say was that they had stopped collecting and selling this data in some fashion.
In the case of healthcare, I ask the question: does having data, even if it is saved in grouped data, violate the Health Insurance Portability and Accountability Act (HIPAA)? If the manufacturer of a drug used to treat hemophilia knows the number of people searching for its drug by ZIP code, directly or indirectly, does this violate at least the spirit of HIPAA?
I understand that Facebook and Google hope you believe that they do not maintain data at an individual level. They say that the data they sell to advertisers excludes individual data. I would argue that by simply reviewing enough of the data they sell, advertisers could match data to individuals. This is how collection companies perform “skip tracing:” finding people to collect unpaid accounts.
I think it is time to look at how much data technology companies have that may constitute a violation of HIPAA. I also think it is time not to consider just individual data, but how data summarized into grouped data may violate HIPAA.
The articles describe a significant 2026 dispute over the misuse of health information exchanged by asserting a treatment purpose through Carequality. (Raths) The core allegation
One of the greatest challenges facing case management today is not a lack of clinical expertise; it is a lack of time. Case managers are
Please log in to your account to comment on this article.
Breast biopsy procedures may be clinically straightforward but accurately translating them into compliant billing can be anything but. In this focused webcast, Shawn Blackburn, CPC, CPMA, CIC, CRC, CCS-P breaks down how imaging guidance, lesion count, laterality, and payer expectations all impact how these procedures should be reported. Through clear explanations and real-world scenarios, you’ll gain practical insight into aligning clinical workflows with billing requirements, avoiding common pitfalls, and ensuring your documentation supports accurate reimbursement and compliance.
Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Sherri L. Clayton, RHIT, CSS. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
